Walgreen's Sales Slide Continues

Walgreens_logoDrug store giant Walgreen Co. (NYSE: WAG) announced this morning that December same-store sales fell 6.1% year-over-year, primarily due to the impact of generic drug sales replacing sales of higher-priced brand-name drugs. Total sales fell 4% from $6.99 billion last year to $6.71 billion.

Pharmacy sales in December fell 4.9%, and same-store pharmacy sales fell 8.9%. Pharmacy sales accounted for 56.7% of monthly sales.

Walgreen noted that a calendar shift was responsible for a negative impact of 2.3% on pharmacy sales, following a 2.9% drop in November. Sales of generic drugs as opposed to brand-name drugs cost the store 3.2% in comparable sales.

There was some positive news. The number of flu shots administered this year has risen from 5.3 million a year ago to 5.5 million. An increase in flu this year has boosted same-store drug sales by 1.4%, and the additional flu shots added 0.7% to sales in December.

Walgreen's stock is down 0.8% this morning, at $37.50 in a 52-week range of $28.53 to $38.41, as virtually every metric reported today was down.


Filed under: 24/7 Wall St. Wire, Retail Tagged: WAG
Read Full Story

Markets

DJIA 25,299.92 112.22 0.45%
NASDAQ 7,870.89 51.19 0.65%
NIKKEI 225 22,204.22 -151.86 -0.68%
HANG SENG 27,323.59 -429.34 -1.55%
DAX 12,352.03 -6.84 -0.06%
USD (per EUR) 1.13 0.00 -0.18%
USD (per CHF) 1.00 0.00 0.38%
JPY (per USD) 111.21 -0.03 -0.02%
GBP (per USD) 1.27 0.00 0.00%